Quarterly report pursuant to Section 13 or 15(d)

STOCK-BASED COMPENSATION

v3.24.2.u1
STOCK-BASED COMPENSATION
6 Months Ended
Jun. 30, 2024
Share-Based Payment Arrangement [Abstract]  
STOCK-BASED COMPENSATION

12. STOCK-BASED COMPENSATION

 

As of June 30, 2024, 675,910 shares of common stock and 16,000 shares of Series B Preferred Stock are available for grant. Permissible awards include incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock, RSUs, performance stock and cash-settled awards and other stock-based awards in the discretion of the Compensation Committee of the Board of Directors including unrestricted stock grants.

 

Certain equity-based RSU agreements contain a provision in which the units shall immediately vest and become converted into common shares at the rate of one share per RSU, immediately after a change in control, as defined in the award agreement.

 

Common and preferred stock RSUs

 

In February 2023, the Compensation Committee approved executive bonuses to be paid in shares of Series B Preferred Stock, with the number of shares and the amount based on specified criteria being achieved during the year 2023. During October 2023, the Compensation Committee approved the issuance of 10,000 of the above shares to one of the executives who retired. The remaining 24,000 shares were forfeited in 2024.

 

In March 2024, the Compensation Committee approved executive bonuses to be paid in shares of Series B Preferred Stock with the number of shares and the amount based on specified criteria being achieved during the year 2024. There were 34,000 shares awarded. These criteria will be evaluated in early 2025. During May 2024, an additional executive bonus with similar terms was approved and 12,000 shares were awarded. For the three and six months ended June 30, 2024, an expense of approximately $265,000 and a net benefit of approximately $443,000, respectively, was recorded. The stock-based compensation benefit was primarily related to prior year bonuses that had been accrued but were not awarded, net of current year bonuses that have been accrued. Stock compensation expense recorded is based on the value of the shares at the grant date and recognized over the service period. The portion of the stock compensation expense to be used for the payment of withholding and payroll taxes is included in accrued compensation in the condensed consolidated balance sheets. The balance of the stock compensation expense has been recorded as additional paid-in capital.

 

The following table summarizes the RSU transactions related to the common and preferred stock under the Company’s equity incentive plan for the six months ended June 30, 2024 and 2023:

  

    Common Stock     Series A
Preferred Stock
    Series B
Preferred Stock
 
Outstanding and unvested shares at January 1, 2024     753,495       -       57,199  
Granted     50,000       -       46,000  
Vested     (366,214 )     -       (14,000 )
Forfeited     (224,032 )     -       (24,000 )
Outstanding and unvested shares at June 30, 2024     213,249       -       65,199  
                         
Outstanding and unvested shares at January 1, 2023     645,475       -       80,462  
Granted     553,191       -       62,000  
Vested     (520,770 )     -       (66,263 )
Forfeited     (29,744 )     -       -  
Outstanding and unvested shares at June 30, 2023     648,152       -       76,199  

 

 

The liability for the 15,037 cash-settled awards outstanding and the liability for withheld taxes in connection with the equity awards was approximately $69,000 and $767,000 at June 30, 2024 and December 31, 2023, respectively, and is included in accrued compensation in the condensed consolidated balance sheets. No amounts were paid in connection with cash-settled awards during both the six months ended June 30, 2024 and 2023.

 

Stock-based compensation expense

 

The following table summarizes the components of share-based compensation expense (benefit) for the three and six months ended June 30, 2024 and 2023:

 

    2024     2023     2024     2023  
    Three Months Ended June 30,     Six Months Ended June 30,  
    2024     2023     2024     2023  
    ($ in thousands)  
Direct operating costs   $ 2     $ 300     $ (43 )   $ 388  
General and administrative     268       848       (428 )     1,453  
Research and development     (68 )     42       (14 )     79  
Selling and marketing     63       312       42       654  
Total stock-based compensation expense (benefit)   $ 265     $ 1,502     $ (443 )   $ 2,574